SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

TerraBioGen Completes Share Transaction

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/24/14 -- TerraBioGen Technologies Inc., a developer of proprietary high-value agriculturally bioactive products, announces that it has completed a private placement.

The private placement is for 21,000 units at $10.00 per unit for proceeds of $210,000. Each unit consists of one common share and one warrant exercisable at $12.00 until January 22, 2019.

These funds will be used to continue the Company's research and development programs and growing trials.

About TerraBioGen

TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agriculturally bioactive products. It is further committed to developing and implementing a global commercialization strategy to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Contacts:
TerraBioGen Technologies Inc.
Blair Heffelfinger
President & CEO
(604) 444-1023 ext 316
(604) 444-1043 (FAX)

TerrabioGen Technologies Inc.
Bob Nowell
CFO & Corporate Secretary
(604) 444-1023 ext 306
(604) 444-1043 (FAX)

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.